Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
about
Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and managementInterventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adultsInterventions for treating AIDS-associated Hodgkin´s Lymphoma in treatment-naive adults with AIDSHodgkin lymphoma and immunodeficiency in persons with HIV/AIDSHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsLung cancer in HIV-infected patients in the combination antiretroviral treatment eraA Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All CancersThe rising challenge of non-AIDS-defining cancers in HIV-infected patientsEpidemic of lung cancer in patients with HIV infectionEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesSevere morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine CohortRisk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.Lung cancer in HIV patients and their parents: a Danish cohort study.HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV StudyOverview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM developmentProspective CT screening for lung cancer in a high-risk population: HIV-positive smokersIncidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studiesA phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.HIV infection is associated with an increased risk for lung cancer, independent of smoking.South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment.Cancer, physical activity, and exerciseRole of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.Hodgkin's Disease in Patients with HIV InfectionCumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veteransLung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug usersReduced risk of prostate cancer in U.S. Men with AIDS.Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.Toxicity and disease-related outcomes after radiotherapy for head and neck cancer in human immunodeficiency virus-positive patientsEBV and HIV-Related LymphomaHuman Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging ProblemPattern of cancer risk in persons with AIDS in Italy in the HAART era.A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.AIDS-related cancer and severity of immunosuppression in persons with AIDS.Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United StatesThe impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.HIV and cancer in GermanyCharacteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.
P2860
Q22251070-765E5713-6A06-4BD4-9586-95E5A646135EQ24245321-18D4D28D-682B-4605-988F-BFA3648928D4Q24245877-1B577E53-3829-4D07-B190-1020C6794AEEQ24685909-C7276F70-89E0-4340-A798-12B1A8453B26Q26740117-2072A052-E668-41C0-8405-6D0F0F212BABQ26769769-AB3CB26E-3085-4D4E-B6CA-13009F21736FQ26777111-514D85BB-B5C2-4ADF-BC55-DD3DD677CA45Q26861496-187D1BA9-916B-4D17-B9F7-86BBF8A948CDQ27000028-25421189-4522-4310-A647-F5F24CBB9136Q27023830-4487BE9B-486D-48D8-8CB8-CEC46C012C95Q28541356-4C881395-0BA8-41EF-A16B-EB3AEDD8EA4AQ30491585-06BE3FD3-768C-4940-88B1-AEDE8ADF6249Q31021219-A83F1AE9-C44F-40D3-B97B-C665EC3ACA61Q33533549-43B3348F-9582-4336-9CCA-B95796D5AFCEQ33564397-27AB98C4-B117-4FD5-9CBD-9738F6E4EA95Q33623439-96472797-AFEB-4F7D-8DF7-3337587EF505Q33624504-6E5712DE-F6AA-49AA-89A2-227D399EA504Q33656320-21AD2279-AE53-41B0-97DB-BBC6C23DB64BQ33686288-85F63E59-3A10-4BD1-8617-D4C04132DA3BQ33834602-8A222025-7C96-488E-B761-92F513739821Q33859760-CDD57DBC-14AC-4D0F-999A-2CF853CD8BD2Q34004946-419F9CFE-9CCD-4530-B960-D6B7D541845AQ34158436-92A3F105-A443-46BB-9B0B-8A133293AB4CQ34169941-97DE348C-694A-4831-AD9E-E7E675818888Q34173349-F97CFFF0-319D-4917-843E-2342BE0B1926Q34283403-98A880AC-9D56-49BA-A291-4E311F1A7586Q34292990-44D0DD01-E279-405F-851D-395620E5E13DQ34332052-3DF7ED09-DDDD-407B-BE96-A1EF82466085Q34348772-AA716C81-E3DA-4535-8097-CE5E81B1A76FQ34403321-EB3A2D13-8D90-429A-9055-F43DCE0FF4D4Q34481497-3BAC717B-8140-414B-BD61-1DB6EF1D493CQ34549450-1EA5BCF4-5CCE-4D02-9210-9BCEA10E42EBQ34571564-D270E5E2-DC9E-48F8-9F28-A5A476BD8420Q34604639-23BEC4A6-852C-46BF-BFCD-1755B5645805Q34612071-E7D7A9AE-A7A0-4F94-93FA-3D66A17CB816Q34636933-F4529159-6600-4B0A-A110-AC17A4B3E523Q34643410-5812332C-20A8-46BF-92E6-B364DDAE21DFQ34648354-93C9BA1F-0E70-4685-86D0-263B8C575BD1Q34660212-6C702FF0-EAB8-458A-8ED1-840E4DE608AFQ34774173-0703E5D5-5ECD-4DFB-866B-61AF20184071
P2860
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@en
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@nl
type
label
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@en
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@nl
prefLabel
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@en
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@nl
P2093
P50
P356
P1476
Incidence of non-AIDS-defining ...... iency virus-infected patients.
@en
P2093
Christian Rabaud
François Boue
Hervé Tissot-Dupont
Jacques Cadranel
Jean-Marie Lang
Magid Herida
Nathalie Plaisance
Régis Kaphan
P304
P356
10.1200/JCO.2003.01.096
P407
P577
2003-09-01T00:00:00Z